byiShook Opinion
Sep 17, 2024 - 13:25
BioNTech stock has climbed 25% over four days as the German biotech rides a round of cancer treatment success from Summit Therapeutics. The post How BioNTech, Up 25% Over Four Days, Is Riding Summit's Coattails To A Recovery appeared first on Investor's Business Daily.
BioNTech stock has climbed 25% over four days as the German biotech rides a round of cancer treatment success from Summit Therapeutics.
The post How BioNTech, Up 25% Over Four Days, Is Riding Summit's Coattails To A Recovery appeared first on Investor's Business Daily.